Phenylpropanolamine
Back to searchMolecule Structure
Scientific Name
Phenylpropanolamine
Description of the Drug
Phenylpropanolamine is a sympathomimetic that was previously used in nasal decongestants and weight loss products, but has been withdrawn by the FDA due to safety risks and lack of efficacy.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00397
http://www.drugbank.ca/drugs/DB00397
Brand Name(s)
Not Available
Company Owner(s)
Ucb Inc, Central Pharmaceuticals Inc, Glaxosmithkline, Sandoz Inc, Alpharma Us Pharmaceuticals Division, Endo Pharmaceuticals Inc, Copley Pharmaceutical Inc, Bf Ascher And Co Inc, Watson Laboratories Inc, Morton Grove Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Alpha-1a adrenergic receptor | SINGLE PROTEIN | AGONIST | CHEMBL229 |
| Norepinephrine transporter | SINGLE PROTEIN | RELEASING AGENT | CHEMBL222 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL98589 | ||
| Human Metabolome Database | HMDB0243518 | ||
| DrugBank | DB00397 | ||
| PubChem: Thomson Pharma | 14747903 | ||
| PubChem | 4786 | ||
| Mcule | MCULE-9503580838 | ||
| Nikkaji | J136.573H | ||
| BindingDB | 50022722 | ||
| DrugCentral | 2149 | ||
| Brenda | 113730 | ||
| rxnorm | PHENYLPROPANOLAMINE | PHENYLPROPANOLAMINE HYDROCHLORIDE | PHENYLPROPANOLAMINE BITARTRATE |
